Miguel Coego Rios

Director of Finance/CFO en CENTOGENE N.V. .

Health Technology

Commercial Services

Perfil

Jose Miguel Coego Rios is currently the Chief Financial Officer, Legal, IT & MD at Centogene NV.
Previously, he held the position of Chief Financial Officer-EMEA & Vice President at Mundipharma International Ltd.
He also served as the Chief Financial Officer-LATAM & GM-Andrea Region at Shire Plc from 2011 to 2019.
Additionally, he worked as the Vice President & General Manager-South Europe at Orphazyme A.

Cargos activos de Miguel Coego Rios

Empresas	Cargo	Inicio
CENTOGENE N.V.	Director of Finance/CFO	31/03/2022

Todos los cargos activos de Miguel Coego Rios

Antiguos cargos conocidos de Miguel Coego Rios.

Empresas	Cargo	Fin
SHIRE	Corporate Officer/Principal	01/01/2019
Mundipharma International Ltd. Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom.	Corporate Officer/Principal	-
ORPHAZYME A/S	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Miguel Coego Rios.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Miguel Coego Rios.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
ORPHAZYME A/S	Health Technology
CENTOGENE N.V.	Commercial Services

Empresas privadas	2
Mundipharma International Ltd. Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom.	Health Technology
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.	Health Technology